{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey Questionnaire- Natural progesterone in Secondary Amenorrhea and Immunomodulation

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Current Practice Patterns

  1. How many patients of partial onset seizure do you see in a month? *

  2. In your clinical practice, what percentage of your total patient population are diagnosed with partial onset seizure? *

  3. In your clinical experience, partial onset seizure is more commonly diagnosed in which age group of patients? *

  4. Which diagnostic tests do you primarily use for Partial onset seizure diagnosis? *

  5. In your clinical practice which of the following guidelines do you primarily use for the management of epileptic patients? *

  6. How often do you prescribe Brivaracetam for Partial onset seizure management? *

  7. Do you have specific considerations when prescribing Brivaracetam to pediatric or elderly patients? *

  8. How do you approach AED selection in pediatric patients (4-16 yrs. age group) with Partial onset seizure? *

  9. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of Partial onset seizure? *
  10. What is the starting dose of Brivaracetam in your practice for partial onset seizure? *

  11. What is the usual maintenance dose of Brivaracetam in your practice for Partial onset seizure? *

  12. What percentage of your patients achieve seizure control with Brivaracetam monotherapy? *

  13. What factors influence your decision to prescribe Brivaracetam over other antiepileptics for Partial onset seizure? *

  14. How do you assess the effectiveness of Brivaracetam in your patients? *

  15. Do you use Brivaracetam as monotherapy or as adjunctive therapy with other medications for Partial onset seizure management? *

  16. What percentage of your partial onset seizure patients currently take Brivaracetam? *

  17. Do you consider Brivaracetam as a first-line treatment option for children (4-16 years) with Partial onset seizure? *

  18. In your clinical practice have you shifted any patient from Levetiracetam to Brivaracetam? *

  19. How often do you review and adjust Brivaracetam dosages in partial onset seizure patients? *

  20. How often do you inform patients about the importance of medication adherence with Brivaracetam? *

  21. What is your approach for managing side effects associated with Antiepileptics? *
  22. In last 3 months of your clinical practice, how many patients have you shifted patients from other anti-epileptics to Brivaracetam *

  23. Mention below the common reasons for switching patients from other antiepileptics to Brivaracetam *
  24. Brivaracetam is more preferred in which group of patients *

  25. What is most preferred education method do you use to educate about epilepsy? *

  26. What factors do you find most commonly contribute to medication non-adherence in epileptic patients? *
  27. What is your preferred approach to addressing medication non-adherence in epileptic patients? *
  28. What insights or recommendations would you offer to fellow neurologists regarding use of Brivaracetam in Partial onset seizure management? *
  29. How would you rate patient's overall experience of Brivaracetam in partial onset seizure management? (5 being very satisfied) *

  30. What are your thoughts on the overall tolerability and efficacy of Brivaracetam compared to other antiepileptics in the management of Partial onset seizure? *